Clinical Trial Update: Compassionate Administration of ZVS101e Injection for Extended Treatment [NA]

View source ↗

Summary

Compassionate-use update for ZVS101e Injection in patients with Bietti Crystalline Corneoretinal Dystrophy carrying biallelic CYP4V2 mutations. The trial is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bietti Crystalline Corneoretinal Dystrophy

Drugs mentioned

• ZVS101e Injection

Snippet

Sponsor: Chigenovo Co., Ltd | Conditions: Patients With Bietti Crystalline Corneoretinal Dystrophy (Carrying Biallelic CYP4V2 Mutations) | NA | Status: ENROLLING_BY_INVITATION